Evidence map›Paper›PMID 19907321›Full record

ReviewCurrent opinion in endocrinology, diabetes, and obesity2010

Gastrin, inflammation, and carcinogenesis.

Celia Chao, Mark R Hellmich

Abstract readReview
In one paragraph

Review in Current opinion in endocrinology, diabetes, and obesity, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
5.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 52 citations in OpenAlex.

  1. Beyond the Stomach: Exploring the Role ofExpert reviews in molecular medicine · 2026
    Review
  2. Effects and mechanisms ofWorld journal of gastroenterology · 2024
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Association ofWorld journal of gastrointestinal oncology · 2020
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Insights into gastric neuroendocrine tumors burden.Chinese journal of cancer research = Chung-kuo yen cheng yen chiu · 2017
    Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Celia ChaoDepartment of Surgery, Sealy Center for Cancer Cell Biology, University of Texas Medical Branch, Galveston, Texas 77555-0722, USA.
Mark R Hellmich
The University of Texas Medical Branch at Galveston · US

Funding

TISSUE CULTURE COREP01DK035608 · NIDDK · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI HELLMICH, MARK R · 1986 to 2010
$14.0M
SURGICAL STUDIES OF GI PEPTIDES--MECHANISMS OF ACTIONR01DK048345 · NIDDK · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI HELLMICH, MARK R · 1994 to 2009
$4.0M
SURGICAL TRAINING IN GASTROINTESTINAL ENDOCRINOLOGYT32DK007639 · NIDDK · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI RADHAKRISHNAN, RAVI S. · 1992 to 2022
$3.6M
Bombesin-Activated Carcinoma Associated Fibroblasts in Colorectal CancerK08CA125209 · NCI · UNIVERSITY OF TEXAS MED BR GALVESTON · PI CHAO, CELIA · 2009 to 2013
$643k
NCI NIH HHS 1K08CA125209NCI NIH HHS K08 CA125209NIDDK NIH HHS 5 R01 DK048345NIDDK NIH HHS P01 DK035608NIDDK NIH HHS P01 DK35608NIDDK NIH HHS R01 DK048345NIDDK NIH HHS T32 DK007639
6 · The paper itself

Abstract

purpose of reviewChronic infection of the gastric mucosa with Helicobacter pylori has long been recognized as a significant risk factor for gastric cancer, and indeed, this model represents the prototypical inflammation-associated cancer. In this review, we present the latest clinical and experimental evidence showing that gastrin peptides and their receptors [the cholecystokinin (CCK2) receptors] potentiate the progression of gastric cancer and other gastrointestinal malignancies in the presence of inflammation. RECENT

findingsWe highlight the feed-forward mechanisms by which gastrin and CCK2 receptor expression are upregulated during inflammation and in gastrointestinal cancers, summarize gastrin's proinflammatory role by inducing the production of cyclooxgenase-2 (COX-2) and interleukin-8 (IL-8), and relate evidence suggesting that gastrin and their receptors modulate the function of immune cells and fibroblasts following cellular stress, injury, repair, as well as during cancer progression. SUMMARY: We discuss trends for future studies directed toward the elucidation of gastrin peptides' role in regulating intercellular molecular signaling mechanisms between local and circulating immune cells, fibroblasts, epithelial cells, and other cell types in the microenvironments of inflammation-related cancers. Elucidation of the molecular and cellular pathways that relate inflammation with cancer may provide additional opportunities to develop complementary therapies that target the inflammatory microenvironment of the cancer.

Indexed as

AnimalsCocarcinogenesisColorectal NeoplasmsCytokinesFeedback, PhysiologicalGastrinsGastritisGastrointestinal NeoplasmsHelicobacter InfectionsHelicobacter pyloriHumansInflammation MediatorsLeukocytesReceptor, Cholecystokinin BCytokinesGastrinsInflammation MediatorsReceptor, Cholecystokinin B

Identifiers

PMID19907321
PMCPMC3970765
OpenAlexW231297418

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.